The Case for Treating Cholesterol Before Plaque Appears | Dr Thomas Dayspring and Dr Dan Soffer

Dr Thomas Dayspring and Dr Dan Soffer, both Masters of the National Lipid Association, join Simon Hill to discuss why nearly all of us have atherosclerosis even when cholesterol is labeled normal. They debate whether ApoB is causal or just necessary, explain the misperception of 'normal' cholesterol, and outline practical tools like LDL-C years and the 2026 dyslipidemia guideline update. The conversation offers an honest look at how experienced clinicians weigh evidence when treating people who feel well.